Page last updated: 2024-09-04

cyc 202 and nu 6140

cyc 202 has been researched along with nu 6140 in 1 studies

Compound Research Comparison

Studies
(cyc 202)
Trials
(cyc 202)
Recent Studies (post-2010)
(cyc 202)
Studies
(nu 6140)
Trials
(nu 6140)
Recent Studies (post-2010) (nu 6140)
979739312011

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)nu 6140 (IC50)
Aurora kinase AHomo sapiens (human)0.067
Cyclin-T1Homo sapiens (human)5.1
Cyclin-dependent kinase 1Homo sapiens (human)5.8
Cyclin-dependent kinase 4Homo sapiens (human)0.94
G2/mitotic-specific cyclin-B1Homo sapiens (human)5.8
Interferon-induced, double-stranded RNA-activated protein kinaseHomo sapiens (human)2
G1/S-specific cyclin-D1Homo sapiens (human)0.94
G1/S-specific cyclin-E1Homo sapiens (human)1.1
Cyclin-dependent kinase 2Homo sapiens (human)0.75
Cyclin-dependent kinase 7Homo sapiens (human)2.3
Cyclin-dependent kinase 9Homo sapiens (human)5.1
Cyclin-HHomo sapiens (human)2.3
CDK-activating kinase assembly factor MAT1Homo sapiens (human)2.3
Cyclin-dependent-like kinase 5 Homo sapiens (human)8.8
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)8.8
Aurora kinase BHomo sapiens (human)0.035

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheng, X; Christ, J; Eisenbrand, G; Merz, KH; Muehlbeyer, S; Thommet, A; Vatter, S; Wölfl, S; Zeller, J1

Other Studies

1 other study(ies) available for cyc 202 and nu 6140

ArticleYear
Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.
    Journal of medicinal chemistry, 2017, 06-22, Volume: 60, Issue:12

    Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chemistry Techniques, Synthetic; Drug Screening Assays, Antitumor; Humans; Indoles; Oximes; Protein Kinase Inhibitors; Receptor, IGF Type 1; Signal Transduction; Solubility; Structure-Activity Relationship

2017